Find policies, billing codes, payers, states, and providers

HCPCS H0003: Alcohol and/or Drug Screening, Laboratory Analysis

HCPCS Level II code H0003 designates laboratory analysis for alcohol and/or drug screening and is widely used across clinical and behavioral health settings to confirm substance exposure or monitor treatment adherence. The code captures toxicology testing performed on patient specimens and is relevant to emergency departments, inpatient and outpatient hospital laboratories, independent diagnostic labs, and substance use treatment programs. Nationally, accurate coding of H0003 supports clinical decision-making, reporting, and payer billing for diagnostic toxicology services.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what H0003 represents, common sites of service, and the clinical context for laboratory-based substance screening. The publication also summarizes typical reimbursement benchmarks, billing nuances, and recent policy considerations that affect coverage and claim adjudication for laboratory toxicology testing. This resource is intended to help coding, billing, and compliance teams understand where H0003 fits within service lines and payer practices.

Customize your policy alerts

Sign up for hcpcs H0003 policy alerts

Get alerted when payer policies referencing H0003 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

HCPCS Level II code H0003 describes alcohol and/or drug screening consisting of laboratory analysis of specimens for the presence of alcohol and/or drugs. This service type is toxicology laboratory testing performed on biological specimens to detect and quantify alcohol and/or controlled substances.

Typical site of service: clinical laboratory or other licensed laboratory setting, including hospital laboratories and independent diagnostic testing facilities where specimen collection and analytic testing occur.

Find policies, billing codes, payers, states, and providers

HCPCS H0003: Alcohol and/or Drug Screening, Laboratory Analysis

Customize your policy alerts

Sign up for hcpcs H0003 policy alerts

Get alerted when payer policies referencing H0003 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

A 34-year-old patient presents to an outpatient substance use treatment clinic for intake evaluation after self-reporting heavy alcohol use and occasional opioid use. The clinic orders a laboratory alcohol and drug screen to confirm recent substance use prior to initiating a medication-assisted treatment plan and to document baseline toxicology. The patient provides urine and blood specimens; the laboratory performs immunoassay screening followed by confirmatory gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–tandem mass spectrometry (LC-MS/MS) for positive results. Results are used in the clinical workflow to guide counseling, medication selection, safety planning, and documentation for treatment eligibility and insurance billing. Typical sites of service include outpatient clinics, community behavioral health centers, emergency departments, and hospital inpatient units when screening is required for acute care or admission. Common scenarios include intake for substance use disorder treatment, pre-procedural screening when alcohol/drug use is a concern, workplace testing referrals, and monitoring during ongoing treatment programs.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier — standard service	Use when no additional modifier applies and the service is furnished as described.
`22`	Increased procedural services	Use when the laboratory testing required substantially greater resources or complexity than typical.
`26`	Professional component	Use when billing only the professional (interpretation) component of the laboratory analysis.
`52`	Reduced services	Use when testing was partially reduced or limited in scope.
`53`	Discontinued procedure	Use when specimen collection/testing was started but discontinued for patient-related reasons.
`55`	Postoperative management only	Use rarely — when billing only for postoperative toxicology monitoring separate from the primary surgical claim.
`56`	Preoperative management only	Use when testing is performed solely for preoperative clearance distinct from other services.
`62`	Two surgeons	Use when two qualified laboratories/providers share responsibility for testing services in a complex consultative arrangement.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for Medicare	Use when an advanced practice provider furnishes or orders the testing under Medicare rules.
`TC`	Technical component	Use when billing only the technical component of the laboratory analysis (equipment, reagents, technician time).
`QK`	Medical direction of two, three, or four concurrent anesthesia procedures	Rarely applicable; include only if anesthesia-related testing coordination is billed with the lab service.
`QX`	CRNA service with medical direction by a physician	Rarely applicable; use only in specialized perioperative testing arrangements involving CRNA.
`QY`	Attending physician of record in teaching setting	Use when the attending physician provides oversight resulting in a billable supervisory role for the testing service in a teaching institution.
`SH`	Diagnostic or therapeutic service furnished personally by a teaching physician in a teaching setting	Use when the teaching physician personally performs or bills for the interpretation component.

Taxonomy Code	Specialty	Notes
`103K00000X`	Addiction Medicine	Physicians who diagnose and manage substance use disorders and order toxicology.
`208D00000X`	Psychiatry & Neurology	Psychiatrists involved in evaluation and treatment of substance-related disorders.
`261QM0800X`	Clinical Laboratory	Clinical laboratory directors and technicians who perform and oversee testing.
`363LA2200X`	Nurse Practitioner	Nurse practitioners in behavioral health and primary care who order and interpret screens.
`207Q00000X`	Family Medicine	Primary care clinicians who order screening as part of general medical care.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F10.20`	Alcohol dependence, uncomplicated	Indicates alcohol dependence; toxicology screening documents recent use and guides treatment planning.
`F11.20`	Opioid dependence, uncomplicated	Opioid use disorder often requires drug screening to confirm recent opioid exposure and monitor therapy.
`F12.20`	Cannabis dependence, uncomplicated	Cannabis use is commonly screened in panels and may influence clinical management or program eligibility.
`F14.20`	Cocaine dependence, uncomplicated	Cocaine exposure is detected in toxicology and is relevant for acute care and treatment decisions.
`R78.0`	Abnormal blood chemistry (drug level)	Used when laboratory testing documents abnormal or detectable drug levels in blood.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80305`	Drug test, presumptive, any number of drug classes; non-validated screen (e.g., immunoassay)	Commonly used for initial immunoassay urine drug screen performed prior to or alongside laboratory analysis billed with `H0003`.
`80307`	Drug test, definitive, each drug class; chromatographic method (e.g., GC-MS)	Used for confirmatory testing (definitive analysis) after a positive screen; often billed in the laboratory workflow following `H0003`.
`80320`	Ethyl alcohol, blood, quantitative	Used when quantitative blood alcohol concentration is required in addition to qualitative screening; complements `H0003` for alcohol testing.
`82570`	Drug assay, other; blood, serum, or plasma (e.g., ethyl alcohol)	Used for specific biochemical assays of alcohol or metabolites when performed by the laboratory organization providing `H0003` services.
`99000`	Handling and/or conveyance of specimen for transfer from the physician's office to a laboratory	Used when additional handling or courier services are required to transport specimens for the laboratory analysis described by `H0003`.

HCPCS H0001: Alcohol and/or Drug Assessment

HCPCS-H0002-BEHAVIORAL-HEALTH-SCREENING-ADMISSION-ELIGIBILITY

HCPCS H0002: Behavioral Health Screening for Admission to Treatment Program

HCPCS-H0004-BEHAVIORAL-HEALTH-COUNSELING-15-MINUTE

HCPCS H0004: Behavioral Health Counseling and Therapy, 15 Minutes

HCPCS-H0005-GROUP-COUNSELING-SUBSTANCE-USE-CLINICIAN

HCPCS H0005: Alcohol/Drug Group Counseling by a Clinician

HCPCS-H0006-ALCOHOL-DRUG-CASE-MANAGEMENT

HCPCS H0006: Alcohol and/or Drug Services, Case Management

HCPCS-H0007-ALCOHOL-DRUG-CRISIS-INTERVENTION-OUTPATIENT

HCPCS H0007: Alcohol and/or Drug Crisis Intervention, Outpatient

HCPCS-H0008-SUB-ACUTE-DETOXIFICATION-HOSPITAL-INPATIENT

HCPCS H0008: Sub-acute Detoxification, Hospital Inpatient

HCPCS-H0009-ACUTE-DETOXIFICATION-HOSPITAL-INPATIENT

HCPCS H0009: Alcohol and/or Drug Services, Acute Detoxification (Hospital Inpatient)

HCPCS-H0010-SUB-ACUTE-RESIDENTIAL-DETOXIFICATION

HCPCS H0010: Sub-Acute Residential Detoxification Services

HCPCS-H0011-ACUTE-DETOXIFICATION-RESIDENTIAL-INPATIENT

HCPCS H0011: Acute Detoxification, Residential Inpatient

Showing 1–10 of 93

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier — standard service	Use when no additional modifier applies and the service is furnished as described.
`22`	Increased procedural services	Use when the laboratory testing required substantially greater resources or complexity than typical.
`26`	Professional component	Use when billing only the professional (interpretation) component of the laboratory analysis.
`52`	Reduced services	Use when testing was partially reduced or limited in scope.
`53`	Discontinued procedure	Use when specimen collection/testing was started but discontinued for patient-related reasons.
`55`	Postoperative management only	Use rarely — when billing only for postoperative toxicology monitoring separate from the primary surgical claim.
`56`	Preoperative management only	Use when testing is performed solely for preoperative clearance distinct from other services.
`62`	Two surgeons	Use when two qualified laboratories/providers share responsibility for testing services in a complex consultative arrangement.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for Medicare	Use when an advanced practice provider furnishes or orders the testing under Medicare rules.
`TC`	Technical component	Use when billing only the technical component of the laboratory analysis (equipment, reagents, technician time).
`QK`	Medical direction of two, three, or four concurrent anesthesia procedures	Rarely applicable; include only if anesthesia-related testing coordination is billed with the lab service.
`QX`	CRNA service with medical direction by a physician	Rarely applicable; use only in specialized perioperative testing arrangements involving CRNA.
`QY`	Attending physician of record in teaching setting	Use when the attending physician provides oversight resulting in a billable supervisory role for the testing service in a teaching institution.
`SH`	Diagnostic or therapeutic service furnished personally by a teaching physician in a teaching setting	Use when the teaching physician personally performs or bills for the interpretation component.

Taxonomy Code	Specialty	Notes
`103K00000X`	Addiction Medicine	Physicians who diagnose and manage substance use disorders and order toxicology.
`208D00000X`	Psychiatry & Neurology	Psychiatrists involved in evaluation and treatment of substance-related disorders.
`261QM0800X`	Clinical Laboratory	Clinical laboratory directors and technicians who perform and oversee testing.
`363LA2200X`	Nurse Practitioner	Nurse practitioners in behavioral health and primary care who order and interpret screens.
`207Q00000X`	Family Medicine	Primary care clinicians who order screening as part of general medical care.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F10.20`	Alcohol dependence, uncomplicated	Indicates alcohol dependence; toxicology screening documents recent use and guides treatment planning.
`F11.20`	Opioid dependence, uncomplicated	Opioid use disorder often requires drug screening to confirm recent opioid exposure and monitor therapy.
`F12.20`	Cannabis dependence, uncomplicated	Cannabis use is commonly screened in panels and may influence clinical management or program eligibility.
`F14.20`	Cocaine dependence, uncomplicated	Cocaine exposure is detected in toxicology and is relevant for acute care and treatment decisions.
`R78.0`	Abnormal blood chemistry (drug level)	Used when laboratory testing documents abnormal or detectable drug levels in blood.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80305`	Drug test, presumptive, any number of drug classes; non-validated screen (e.g., immunoassay)	Commonly used for initial immunoassay urine drug screen performed prior to or alongside laboratory analysis billed with `H0003`.
`80307`	Drug test, definitive, each drug class; chromatographic method (e.g., GC-MS)	Used for confirmatory testing (definitive analysis) after a positive screen; often billed in the laboratory workflow following `H0003`.
`80320`	Ethyl alcohol, blood, quantitative	Used when quantitative blood alcohol concentration is required in addition to qualitative screening; complements `H0003` for alcohol testing.
`82570`	Drug assay, other; blood, serum, or plasma (e.g., ethyl alcohol)	Used for specific biochemical assays of alcohol or metabolites when performed by the laboratory organization providing `H0003` services.
`99000`	Handling and/or conveyance of specimen for transfer from the physician's office to a laboratory	Used when additional handling or courier services are required to transport specimens for the laboratory analysis described by `H0003`.

HCPCS H0001: Alcohol and/or Drug Assessment

HCPCS-H0002-BEHAVIORAL-HEALTH-SCREENING-ADMISSION-ELIGIBILITY

HCPCS H0002: Behavioral Health Screening for Admission to Treatment Program

HCPCS-H0004-BEHAVIORAL-HEALTH-COUNSELING-15-MINUTE

HCPCS H0004: Behavioral Health Counseling and Therapy, 15 Minutes

HCPCS-H0005-GROUP-COUNSELING-SUBSTANCE-USE-CLINICIAN

HCPCS H0005: Alcohol/Drug Group Counseling by a Clinician

HCPCS-H0006-ALCOHOL-DRUG-CASE-MANAGEMENT

HCPCS H0006: Alcohol and/or Drug Services, Case Management

HCPCS-H0007-ALCOHOL-DRUG-CRISIS-INTERVENTION-OUTPATIENT

HCPCS H0007: Alcohol and/or Drug Crisis Intervention, Outpatient

HCPCS-H0008-SUB-ACUTE-DETOXIFICATION-HOSPITAL-INPATIENT

HCPCS H0008: Sub-acute Detoxification, Hospital Inpatient

HCPCS-H0009-ACUTE-DETOXIFICATION-HOSPITAL-INPATIENT

HCPCS H0009: Alcohol and/or Drug Services, Acute Detoxification (Hospital Inpatient)

HCPCS-H0010-SUB-ACUTE-RESIDENTIAL-DETOXIFICATION

HCPCS H0010: Sub-Acute Residential Detoxification Services

HCPCS-H0011-ACUTE-DETOXIFICATION-RESIDENTIAL-INPATIENT

HCPCS H0011: Acute Detoxification, Residential Inpatient

Showing 1–10 of 93

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

HCPCS H0003: Alcohol and/or Drug Screening, Laboratory Analysis

Sign up for hcpcs H0003 policy alerts

Billing Code Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

HCPCS H0003: Alcohol and/or Drug Screening, Laboratory Analysis

Sign up for hcpcs H0003 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References